The result of the Chinese vaccine Phase 3 study applied in Turkey was announced. The vaccine efficacy rate was determined as 83 and a half percent. According to the results of the study, the rate of the vaccine preventing hospitalization is 100 percent. The results of the study are Hacettepe University faculty member Prof. Dr. Murat Akova explained."” China vaccine efficacy of 83.5 percent ‘(announced results Turkey)"
According to the news of Xinhua, it was reported that the single-dose Recombinant vaccine was approved for widespread use, in a statement made by the Chinese National Medicines Administration. The recombinant was noted to be China’s first adenovirus-based vaccine developed by a research team led by Chen Wei, a researcher at the Chinese Military Medical Institute. It was stated that the recombinant vaccine can be applied to those over the age of 18 and can…"China approves more widespread use of a Covid-19 vaccine"
Two more vaccines were approved for use in China. China National Medicines Association, CanSino Biologics and the state-affiliated Sinopharm companies have been given conditional approval for their vaccines. Both vaccines have been used in a limited way within the scope of emergency use approval for a while. thus The number of vaccines administered on the masses in China has increased to four. The vaccine of CanSino, the first single-dose vaccine candidate produced in China, reaches…"Permission to use two more vaccines against corona virus in China"